Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Operating expenses:
Research and development	$ 16,884	$ 10,783	$ 46,406	$ 26,401
General and administrative	4,484	3,369	12,937	10,984
Total operating expenses	21,368	14,152	59,343	37,385
Loss from operations	(21,368)	(14,152)	(59,343)	(37,385)
Other income (expense):
Interest income	1,804	560	4,236	898
Other income (expense):	1	4	(1)	(2)
Total other income	1,805	564	4,235	896
Net loss	(19,563)	(13,588)	(55,108)	(36,489)
Comprehensive loss:
Net loss	(19,563)	(13,588)	(55,108)	(36,489)
Other comprehensive loss:
Unrealized (loss) gain on securities	(22)	14	243	(712)
Comprehensive loss	$ (19,585)	$ (13,574)	$ (54,865)	$ (37,201)
Net loss per share, basic	$ (0.71)	$ (0.56)	$ (2.13)	$ (1.49)
Net loss per share, diluted	$ (0.71)	$ (0.56)	$ (2.13)	$ (1.49)
Weighted-average shares of common stock outstanding, basic	27,640,542	24,454,786	25,872,118	24,425,390
Weighted-average shares of common stock outstanding, diluted	27,640,542	24,454,786	25,872,118	24,425,390